Compositions and methods involving an essential Staphylococcus aureus gene and its encoded protein
    11.
    发明授权
    Compositions and methods involving an essential Staphylococcus aureus gene and its encoded protein 失效
    涉及金黄色葡萄球菌基因及其编码蛋白的组成和方法

    公开(公告)号:US07101969B1

    公开(公告)日:2006-09-05

    申请号:US09689952

    申请日:2000-10-12

    IPC分类号: C07K14/00 G01N33/53

    CPC分类号: C12Q1/025

    摘要: This invention relates to newly identified polynucleotides and polypeptides, and their production and uses, as well as their variants, agonists and antagonists, and their uses. In particular, the invention relates to polynucleotides and polypeptides of a Staphylococcus aureus (S. aureus) DnaI related protein, as well as its variants. The invention also relates to a specific interaction between the S. aureus DnaI related protein or specific regions thereof, and a growth-inhibitory protein encoded by the S. aureus bacteriophage 77 genome. The phage open reading frame (ORF) product interacts with amino acids 150–313 of S. aureus DnaI polypeptide, and the invention relates to the use of this interaction target site as the basis of drug screening assays. Accordingly, the invention provides a method for the inhibition of bacterial growth, and the treatment of bacterial infection via the inhibition of DnaI.

    摘要翻译: 本发明涉及新鉴定的多核苷酸和多肽及其生产和用途,以及它们的变体,激动剂和拮抗剂及其用途。 特别地,本发明涉及金黄色葡萄球菌(金黄色葡萄球菌)DnaI相关蛋白的多核苷酸和多肽及其变体。 本发明还涉及金黄色葡萄球菌DnaI相关蛋白或其特定区域之间的特异性相互作用以及由金黄色葡萄球菌噬菌体77基因组编码的生长抑制性蛋白。 噬菌体开放阅读框(ORF)产物与金黄色葡萄球菌DnaI多肽的氨基酸150-313相互作用,本发明涉及使用该相互作用靶位点作为药物筛选测定的基础。 因此,本发明提供了通过抑制DnaI来抑制细菌生长和细菌感染的治疗方法。